Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at
暂无分享,去创建一个
J. Trojan | G. Folprecht | R. Hofheinz | S. Al-Batran | S. Probst | E. Jäger | T. Goetze | C. Pauligk | N. Homann | H. Kopp | J. Meiler | G. Haag | N. Prasnikar | H. Schmalenberg | Barbara Luley Kim | H. Schmiegel Wolff | C. Thuss-Patience Peter | H. Schuler Martin